A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS

被引：0

作者：

Montalban, Xavier ^{[1
]}

Hemmer, Bernhard ^{[2
,3
]}

Rammohan, Kottil W. ^{[4
]}

Giovannoni, Gavin ^{[5
]}

De Seze, Jerome ^{[6
]}

Bar-Or, Amit ^{[7
]}

Arnold, Douglas L. ^{[7
,8
]}

Sauter, Annette ^{[9
]}

Masterman, Donna ^{[10
]}

Fontoura, Paulo ^{[9
]}

Chin, Peter ^{[11
]}

Garren, Hideki ^{[9
]}

Wolinsky, Jerry S. ^{[12
]}

机构：

[1] Hosp Vall dHebron Univ, Barcelona, Spain

[2] Tech Univ Munich, D-80290 Munich, Germany

[3] Munich Cluster Syst Neurol SyNergy, Munich, Germany

[4] Univ Miami, Miami, FL USA

[5] Queen Mary Univ London, London, England

[6] Univ Hosp Strasbourg, Strasbourg, France

[7] McGill Univ, Montreal, PQ, Canada

[8] NeuroRx Res, Montreal, PQ, Canada

[9] F Hoffmann La Roche & Co Ltd, Basel, Switzerland

[10] Genentech Inc, San Francisco, CA 94080 USA

[11] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA

[12] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P023

引用

页码：17 / 17

页数：1

共 50 条

[41] A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
Taku Kinoshita
Masahiro Shinoda
Yasuhiro Nishizaki
Katsuya Shiraki
Yuji Hirai
Yoshiko Kichikawa
Kenji Tsushima
Masaharu Shinkai
Naoyuki Komura
Kazuo Yoshida
Yasutoshi Kido
Hiroshi Kakeya
Naoto Uemura
Junichi Kadota
BMC Medicine, 20
[42] Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial
Yiannakou, Yan
Bouchoucha, Michel
Schiefke, Ingolf
Piessevaux, Hubert
Filip, Rafal
Stephenson, David
Green, Alexandra
Levine, Amy
GASTROENTEROLOGY, 2014, 146 (05) : S160 - S160
[43] Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study
Okubo, Kimihiro
Gotoh, Minoru
Asako, Mikiya
Nomura, Yasuyuki
Togawa, Michinori
Saito, Akihiro
Honda, Takayuki
Ohashi, Yoshihiro
ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 97 - 105
[44] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Andrew Menzies-Gow
Sandhia Ponnarambil
John Downie
Karin Bowen
Åsa Hellqvist
Gene Colice
Respiratory Research, 21
[45] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Menzies-Gow, Andrew
Ponnarambil, Sandhia
Downie, John
Bowen, Karin
Hellqvist, Asa
Colice, Gene
RESPIRATORY RESEARCH, 2020, 21 (01)
[46] EFFICACY AND SAFETY OF CELECOXIB COMPARED WITH PLACEBO AND ETODOLAC FOR ACUTE POSTOPERATIVE PAIN: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, CONTROLLED TRIAL
Ishiguro, Naoki
Hanaoka, Akio
Okada, Toshiyuki
Ito, Masanori
NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (1-2): : 81 - 93
[47] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Reetz, Kathrin
Hilgers, Ralf-Dieter
Isfort, Susanne
Dohmen, Marc
Didszun, Claire
Fedosov, Kathrin
Kistermann, Jennifer
Mariotti, Caterina
Durr, Alexandra
Boesch, Sylvia A.
Klopstock, Thomas
Garrido, Francisco Javier Rodriguez de Rivera
Schoels, Ludger
Klockgether, Thomas
Pandolfo, Massimo
Korinthenberg, Rudolf
Lavin, Philip
Molenberghs, Geert
Libri, Vincenzo
Giunti, Paola
Festenstein, Richard
Schulz, Joerg B.
NEUROLOGICAL RESEARCH AND PRACTICE, 2019, 1 (01):
[48] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Kathrin Reetz
Ralf-Dieter Hilgers
Susanne Isfort
Marc Dohmen
Claire Didszun
Kathrin Fedosov
Jennifer Kistermann
Caterina Mariotti
Alexandra Durr
Sylvia Boesch
Thomas Klopstock
Francisco Javier Rodríguez de Rivera Garrido
Ludger Schöls
Thomas Klockgether
Massimo Pandolfo
Rudolf Korinthenberg
Philip Lavin
Geert Molenberghs
Vincenzo Libri
Paola Giunti
Richard Festenstein
Jörg B. Schulz
Neurological Research and Practice, 1
[49] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
Hiroyoshi Ohta
Hiroshi Oka
Chie Usui
Masayuki Ohkura
Makoto Suzuki
Kusuki Nishioka
Arthritis Research & Therapy, 14
[50] Lamotrigine for painful polyneuropathy: Randomized, placebo-controlled, double-blind, parallel-group pilot study
Hart, DE
Riback, PS
Calder, CS
Storey, JR
Wymer, JP
Potter, DL
ANNALS OF NEUROLOGY, 2001, 50 (03) : S35 - S35

← 1 2 3 4 5 →